Understanding Breast Cancer Family History is crucial for risk assessment and personalized medicine. This resource provides information on documenting Family History of Breast Cancer, including relevant medical coding terms and clinical documentation best practices. Learn about genetic predisposition to breast cancer and its implications for healthcare professionals involved in diagnosis, treatment planning, and preventative care. Explore how to accurately capture and code a family history positive for breast cancer for improved patient outcomes.
Also known as
Family history of malignant neoplasm of breast
Personal history of family member with breast cancer.
Genetic susceptibility to malignant neoplasm of breast
Increased risk of breast cancer due to inherited genetic factors.
Factors influencing health status and contact with health services
Includes family history and genetic predisposition codes.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is there a history of breast cancer in one or more first-degree relatives?
When to use each related code
| Description |
|---|
| Increased risk of breast cancer due to family history. |
| Genetic mutations linked to higher breast cancer risk. |
| Benign breast changes increasing cancer risk slightly. |
Missing laterality (right, left, bilateral) can impact risk assessment and treatment planning. Proper coding needed for accurate staging and reimbursement.
Miscoding family history as a current diagnosis can lead to incorrect treatment and inflated quality metrics. Clear documentation is crucial.
Coding must reflect the specific type of family history (e.g., mother, sister). This impacts genetic counseling and preventative care.
Q: How should I interpret a strong family history of breast cancer when assessing a patient's risk, particularly with multiple affected relatives and early-onset diagnoses?
A: A strong family history of breast cancer, especially with multiple affected first-degree relatives (mother, sister, daughter) and early-onset diagnoses (before age 50), significantly increases a patient's risk. Consider factors like the number of affected relatives, their age at diagnosis, the presence of bilateral breast cancer, and any occurrences of ovarian or other related cancers. Explore how risk assessment tools, such as the Tyrer-Cuzick model or the BOADICEA model, can help quantify this risk and guide management decisions, including enhanced screening or genetic testing for mutations like BRCA1/2. Learn more about incorporating family history details into a comprehensive breast cancer risk assessment.
Q: What are the key genetic testing recommendations for patients with a family history of breast cancer, and how do I choose the most appropriate test based on the family's specific cancer history?
A: Genetic testing recommendations for patients with a family history of breast cancer depend on several factors, including the number of affected relatives, the types of cancers present in the family (e.g., breast, ovarian, prostate), and the age of onset. While BRCA1/2 testing is common, other genes like PALB2, TP53, and PTEN may also be relevant. Consider implementing a multi-gene panel test when there's a complex family history or when BRCA1/2 testing is negative despite a high suspicion of hereditary cancer. Explore how genetic counseling can help determine the most appropriate testing strategy and interpret results accurately, especially for patients with variants of uncertain significance (VUS).
Patient presents with a concern regarding breast cancer family history. She reports a significant family history of breast cancer, increasing her risk for developing the disease. Maternal aunt diagnosed with invasive ductal carcinoma at age 48, maternal grandmother diagnosed with breast cancer at age 62 (specific type unknown), and a paternal cousin diagnosed with breast cancer at age 55. The patient denies any personal history of breast lumps, nipple discharge, or skin changes. She is currently asymptomatic. Physical examination reveals no palpable breast masses or lymphadenopathy. Assessment includes a strong family history of breast cancer, suggesting a potential genetic predisposition. Differential diagnoses include benign breast conditions and hereditary breast and ovarian cancer syndrome. Plan includes discussion of genetic testing options such as BRCA1 and BRCA2 mutation analysis, increased breast cancer surveillance including mammograms and breast MRIs, and referral to a genetic counselor for risk assessment and management. Patient education provided regarding breast self-examination, lifestyle modifications for breast cancer risk reduction, and the importance of regular follow-up. ICD-10 code Z80.3 (family history of malignant neoplasm of breast) is documented. CPT codes for the consultation, genetic counseling referral, and potential imaging studies are also applicable and will be documented upon completion. Further evaluation and management will be based on genetic testing results and individual risk stratification.